Retraction notice to "Randomized controlled trial of rivaroxaban versus warfarin in the management of acute non-neoplastic portal vein thrombosis" [Vascular Pharmacology 113 (2019) 86-91]

Vascul Pharmacol. 2023 Jan 12:107142. doi: 10.1016/j.vph.2023.107142. Online ahead of print.NO ABSTRACTPMID:37573190 | DOI:10.1016/j.vph.2023.107142

Source: Vascular Pharmacology - August 12, 2023 Category: Drugs & Pharmacology Authors: Amr Shaaban Hanafy Sherief Abd-Elsalam Mohammed M Dawoud Source Type: research